Clinical Pharmacokinetics and Pharmacodynamics of Colistin

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical Pharmacokinetics

• Publication date

  2017-05-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s40262-017-0561-1PMID 28550595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Colistin loading dose: evaluation of the published pharmacokinetic and clinical data.

  2016cited by this paper
• In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model

  2016cited by this paper
• Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance

  2016influential reference
• Transferable resistance to colistin: a new but old threat.

  2016cited by this paper
• Dosing Guidance for Intravenous Colistin in Critically Ill Patients

  2016influential reference
• Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?

  2016cited by this paper
• Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.

  2016cited by this paper
• Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model.

  2016cited by this paper
• Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance Mechanisms

  2016cited by this paper
• Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.

  2016cited by this paper
• Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model

  2016cited by this paper
• Synergistic combinations of polymyxins.

  2016cited by this paper
• Intrathecal or intraventricular colistin: a review.

  2016cited by this paper
• Transport mechanisms at the pulmonary mucosa: implications for drug delivery

  2016cited by this paper
• Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.

  2016cited by this paper
• Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis

  2016cited by this paper
• Colistin Use in Patients With Reduced Kidney Function.

  2016influential reference
• Development, validation and application of an ultra high performance liquid chromatographic-tandem mass spectrometric method for the simultaneous detection and quantification of five different classes of veterinary antibiotics in swine manure.

  2016cited by this paper
• Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa

  2016cited by this paper
• Polymyxin B versus colistin: an update

  2015influential reference
• In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam

  2015cited by this paper
• Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.

  2015cited by this paper
• Development and validation of a high-performance liquid chromatography-fluorescence detection method for the accurate quantification of colistin in human plasma.

  2015cited by this paper
• In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.

  2015cited by this paper
• Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.

  2015cited by this paper
• In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa

  2015cited by this paper
• Feasibility of microdialysis for determination of protein binding and target site pharmacokinetics of colistin in vivo

  2015cited by this paper
• Mucin Binding Reduces Colistin Antimicrobial Activity

  2015cited by this paper
• Colistin, mechanisms and prevalence of resistance

  2015influential reference
• Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes

  2015cited by this paper
• Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus.

  2015cited by this paper
• Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity

  2015cited by this paper
• Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients

  2015influential reference
• New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.

  2015cited by this paper
• Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates

  2015cited by this paper
• The safety of polymyxin antibiotics

  2015cited by this paper
• Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.

  2015cited by this paper
• A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii.

  2015cited by this paper
• Colistin for lung infection: an update

  2015cited by this paper
• Colistin: How should It Be Dosed for the Critically Ill?

  2015cited by this paper
• Gastric stability and oral bioavailability of colistin sulfate in pigs challenged or not with Escherichia coli O149: F4 (K88).

  2015cited by this paper
• Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.

  2015influential reference
• In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.

  2014cited by this paper
• Effects of Antibiotic Physicochemical Properties on Their Release Kinetics from Biodegradable Polymer Microparticles

  2014cited by this paper
• Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 2. Colistin

  2014cited by this paper
• Perioperative selective decontamination of the digestive tract and standard antibiotic prophylaxis versus standard antibiotic prophylaxis alone in elective colorectal cancer patients.

  2014cited by this paper
• New Colistin Population Pharmacokinetic Data in Critically Ill Patients Suggesting an Alternative Loading Dose Rationale

  2014influential reference
• A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing.

  2014cited by this paper
• Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician.

  2014cited by this paper
• Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration

  2014influential reference
• Differential Expression of Two-Component Systems, pmrAB and phoPQ, with Different Growth phases of Klebsiella pneumoniae in the Presence or Absence of Colistin

  2014cited by this paper
• Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients

  2014cited by this paper
• Validation of a Model To Predict the Risk of Nephrotoxicity in Patients Receiving Colistin

  2014cited by this paper
• An observational multi-cohort study on the use and safety of Combivir scored tablets among HIV-infected children and adolescents. Report to the European Medicines Agency (EMA)/ Committee for Medicinal Products for Human Use (CHMP)

  2014cited by this paper
• Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill Experiments

  2014cited by this paper
• In Vitro Synergistic Activity of Colistin and Ceftazidime or Ciprofloxacin Against Multidrug-Resistant Clinical Strains of Pseudomonas aeruginosa

  2014cited by this paper
• Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination

  2014cited by this paper
• In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii

  2014cited by this paper
• Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.

  2014cited by this paper
• Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 3. Tobramycin

  2014cited by this paper
• Colistin and polymyxin B: peas in a pod, or chalk and cheese?

  2014cited by this paper
• Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.

  2013cited by this paper
• Effective removal of colistin methanesulphonate and formed colistin during intermittent haemodialysis in a patient infected by polymyxin-only-susceptible Pseudomonas aeruginosa

  2013cited by this paper
• Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment

  2013influential reference
• Combined Intravenous and Intraventricular Administration of Colistin Methanesulfonate in Critically Ill Patients with Central Nervous System Infection

  2013cited by this paper
• Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial.

  2013cited by this paper
• Pharmacokinetics of four different brands of colistimethate and formed colistin in rats.

  2013cited by this paper
• Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative Bacilli

  2013cited by this paper
• A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity

  2013cited by this paper
• Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study

  2013cited by this paper
• Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

  2013cited by this paper
• Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.

  2013cited by this paper
• In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii

  2013cited by this paper
• Species-Dependent Blood-Brain Barrier Disruption of Lipopolysaccharide: Amelioration by Colistin In Vitro and In Vivo

  2013cited by this paper
• Population Pharmacokinetics of Colistin Methanesulfonate in Rats: Achieving Sustained Lung Concentrations of Colistin for Targeting Respiratory Infections

  2013cited by this paper
• Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.

  2013cited by this paper
• Megalin Contributes to Kidney Accumulation and Nephrotoxicity of Colistin

  2013cited by this paper
• In Vitro Responses of Acinetobacter baumannii to Two- and Three-Drug Combinations following Exposure to Colistin and Doripenem

  2013cited by this paper
• Population Pharmacokinetic Analysis of Colistin in Burn Patients

  2013cited by this paper
• Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system.

  2013cited by this paper
• Optimization of Colistin Dosage in the Treatment of Multiresistant Gram-negative Infections

  2013cited by this paper
• Emergence of Colistin Resistance in Enterobacteriaceae after the Introduction of Selective Digestive Tract Decontamination in an Intensive Care Unit

  2013cited by this paper
• Activity of Tigecycline in Combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-Producing Enterobacteriaceae in a Murine Thigh Infection Model

  2013cited by this paper
• Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides

  2013cited by this paper
• Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration

  2012cited by this paper
• Pharmacokinetics of Colistin in Cerebrospinal Fluid after Intraventricular Administration of Colistin Methanesulfonate

  2012cited by this paper
• Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients

  2012cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled Trial of Selective Digestive Decontamination Using Oral Gentamicin and Oral Polymyxin E for Eradication of Carbapenem-Resistant Klebsiella pneumoniae Carriage

  2012cited by this paper
• Colistin pharmacokinetics: the fog is lifting.

  2012cited by this paper
• Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study

  2012cited by this paper
• Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

  2012cited by this paper
• Colistin Distribution in the Peritoneal Fluid of a Patient with Severe Peritonitis

  2012cited by this paper
• The Two-Component System CprRS Senses Cationic Peptides and Triggers Adaptive Resistance in Pseudomonas aeruginosa Independently of ParRS

  2012cited by this paper
• Selective decontamination of the oral and digestive tract in surgical versus non‐surgical patients in intensive care in a cluster‐randomized trial

  2012cited by this paper
• In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates

  2012cited by this paper
• ‘Old’ antibiotics for emerging multidrug-resistant bacteria

  2012cited by this paper
• Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?

  2012cited by this paper
• Inhaled colistin for lower respiratory tract infections

  2012cited by this paper
• Emergence of OXA-48 and OXA-181 Carbapenemases among Enterobacteriaceae in South Africa and Evidence of In Vivo Selection of Colistin Resistance as a Consequence of Selective Decontamination of the Gastrointestinal Tract

  2012cited by this paper
• Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.

  2012cited by this paper

• Treating Extensively Drug-Resistant Acinetobacter baumannii: Considerations for Host Characteristics and Type of Infections

  2026cites this paper
• Reviving Old Antibiotics: New Indications and Therapeutic Perspectives-A Review.

  2026cites this paper
• Colistin residues and colistin-resistant Enterobacteriaceae in agricultural soils: Sources, risks, and remediation strategies.

  2026cites this paper
• Klebsiella pneumoniae and pyogenic liver abscess: Emerging clinical threats, virulence mechanisms and therapeutic strategies (Review)

  2026cites this paper
• Airborne free DNA in chicken farms: The overlooked traits in microbial diversity, viral composition, and antimicrobial resistance risk.

  2025cites this paper
• Challenges in the management of multidrug-resistant Gram-negative bacterial meningitis in children: a decade of clinical insights

  2025cites this paper
• In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria

  2025cites this paper
• Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: results of the COL-ECMO2022 trial.

  2025cites this paper
• Prevention of donation-related infections: investigating the use of antibiotics in the decontamination of preservation fluid for organ transplantation

  2025cites this paper
• Disposition kinetics and tissue residues of Lincomycin following intravenous, intramuscular and single and multiple oral dosing in domestic geese (Anser anser domesticus)

  2025cites this paper
• Medicinal applications and environmental fate of antimicrobial peptides: a review

  2025cites this paper
• Comparative efficacy of intravenous versus intravenous combined with intrathecal/intracerebral ventricle injection of polymyxin B for Acinetobacter baumannii intracranial infection: a retrospective study.

  2025cites this paper
• Disposition of colistin in critically-ill patients on sustained low-efficiency dialysis: a population pharmacokinetic study.

  2025cites this paper
• One Health at Risk: Plasmid-Mediated Spread of mcr-1 Across Clinical, Agricultural, and Environmental Ecosystems

  2025cites this paper
• Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli

  2025cites this paper
• Optimizing colistin dosing in patients undergoing continuous kidney replacement therapy: critical considerations for intensivists

  2025cites this paper
• Two novel rapid colorimetric methods for determination of colistin susceptibility in Enterobacterales isolates.

  2025cites this paper
• Chondroitin Sulfate/Cyanocobalamin–Chitosan Polyelectrolyte Complexes for Improved Oral Delivery of Colistin

  2025cites this paper
• Ultra-Specific G-Quadruplex-Colistin Interaction for Efficient Transcriptome-Wide G4 Mapping.

  2025cites this paper
• Genomic diversity of mcr-carrying plasmids and the role of type IV secretion systems in IncI2 plasmids conjugation

  2025cites this paper
• Colistin does not self-assemble at physiologically relevant conditions

  2025cites this paper
• Liquid crystalline coatings loaded with colistin for preventing development of biofilms on orthopedic implants.

  2025cites this paper
• Colistin antibacterial activity, clinical effectiveness, and mechanisms of intrinsic and acquired resistance.

  2025cites this paper
• DNA Polymerase IV dinB Favors the Adaptive Fitness of mcr‐carrying Bacteria Through a Negative Feedback Regulatory Mechanism

  2025cites this paper
• Potential Use of Selected Natural Compounds with Anti-Biofilm Activity

  2025cites this paper
• The Public Health Risks of Colistin Resistance in Dogs and Cats: A One Health Perspective Review

  2025influential citation
• Pharmacokinetics of colistin sulfate and berberine sulfate following intramuscular injection as single agents or in combination in swine

  2025cites this paper
• Using honey bee colonies to monitor phenotypic and genotypic resistance to colistin.

  2024cites this paper
• Evaluation of the Effect of N-acetylcysteine in the Prevention of Colistin Nephrotoxicity in Critically Ill Patients: A Randomized Controlled Trial

  2024cites this paper
• The First Report of mcr-1-Carrying Escherichia coli, Isolated from a Clinical Sample in the North-East of Romania

  2024cites this paper
• Evaluation and Molecular Characterization of Colistin-Resistant Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae from the Infected Wounds of Hospitalized Patients

  2024cites this paper
• High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy

  2024cites this paper
• Population Pharmacokinetic Analysis and Dosing Optimization of Colistin Sulfate in Lung Transplant Recipients with Pneumonia: A Prospective Study.

  2024cites this paper
• Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomics

  2024cites this paper
• Pharmacokinetics and Tissue Residues of Colistin Following Intravenous, and Single and Repeated Oral Dosing in Domestic Geese (anser anser domesticus).

  2024cites this paper
• Decoding the origins, spread, and global risks of mcr-9 gene

  2024cites this paper
• Clinical Effectiveness and Safety of Colistin Sulphate in Treating Infections Caused by Carbapenem-Resistant Organisms and Analysis of Influencing Factors

  2024cites this paper
• Metabolomics highlights biochemical perturbations occurring in the kidney and liver of mice administered a human dose of colistin

  2024cites this paper
• Optimizing Treatment for Carbapenem-Resistant Acinetobacter baumannii Complex Infections: A Review of Current Evidence

  2024cites this paper
• The impact of colistin-based regimens on mortality compared to other antimicrobials in patients with carbapenem-resistant Enterobacterales bacteremia in South African hospitals: a cross-sectional study

  2024cites this paper
• Transcriptomic investigations of polymyxins and colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii

  2024cites this paper
• Verapamil increases susceptibility of colistin-resistant Acinetobacter baumannii to colistin.

  2024cites this paper
• NhaA: A promising adjuvant target for colistin against resistant Escherichia coli.

  2024cites this paper
• Is intrathecal or intraventricular therapy with polymyxins or aminoglycosides still needed for improving the outcome of post-neurosurgical extensively/multi drug-resistant (XDR/MDR) Gram-negative bacteria (-GNB) related meningitis/ventriculitis in the current era of novel beta-lactams beta-lactam/be

  2024cites this paper
• Inhibition of inosine metabolism of the gut microbiota decreases testosterone secretion in the testis

  2024cites this paper
• Antibiotic susceptibility patterns at the Médecins Sans Frontières (MSF) Acute Trauma Hospital in Aden, Yemen: a retrospective study from January 2018 to June 2021

  2024cites this paper
• Liposomal Formulation Reduces Transport and Cell Uptake of Colistin in Human Lung Epithelial Calu-3 Cell and 3D Human Lung Primary Tissue Models

  2024cites this paper
• Antimicrobial Consumption and Resistance of Restricted Antibiotics in a Level III Government Hospital

  2024influential citation
• Therapeutic Drug monitoring of colistin in critically ill patients: A narrative review

  2023cites this paper
• A simple and green capillary electrophoresis-mass spectrometry method for therapeutic drug monitoring of colistin in clinical plasma samples

  2023cites this paper
• Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review

  2023cites this paper
• Efficacy of Intravenous Colistin Monotherapy Versus Colistin Combined With Meropenem in Patients With Multidrug-Resistant Infections: A Retrospective Observational Study

  2023cites this paper
• Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant Escherichia coli, In Vitro and in a Murine Peritonitis Model

  2023cites this paper
• Polymyxin B and fusidic acid, a novel potent synergistic combination against Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance

  2023cites this paper
• Eugenol works synergistically with colistin against colistin-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates by enhancing membrane permeability

  2023cites this paper
• Fierce poison to others: the phenomenon of bacterial dependence on antibiotics

  2023cites this paper
• Susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis Isolated from Pigs in Hungary between 2018 and 2021

  2023cites this paper
• Collateral sensitivity: An evolutionary trade‐off between antibiotic resistance mechanisms, attractive for dealing with drug‐resistance crisis

  2023cites this paper
• Synergy with Farnesol Rejuvenates Colistin Active against Col-R Gram-Negative Bacteria in Vitro and in Vivo.

  2023cites this paper
• High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review

  2023cites this paper
• In vivo evaluation of nephrotoxicity and neurotoxicity of colistin formulated with sodium deoxycholate sulfate in a mice model

  2023cites this paper
• A novel lytic bacteriophage against colistin-resistant Escherichia coli isolated from different animals

  2023cites this paper
• Mapping of new pharmacological alternatives in the face of the emergence of antibiotic resistance in COVID-19 patents treated for opportunistic respiratory bacterial pathogens.

  2022cites this paper
• In Vitro Activity of Amphotericin B in Combination with Colistin against Fungi Responsible for Invasive Infections

  2022cites this paper
• Identification of mcr-1-positive multidrug-resistant Escherichia coli isolates from clinical samples in Shanghai, China.

  2022cites this paper
• Pharmacokinetics and pharmacodynamics of peptide antibiotics.

  2022cites this paper
• The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations

  2022cites this paper
• Evaluation of mechanisms of colistin resistance in Klebsiella pneumoniae strains isolated from patients with urinary tract infection in ICU

  2022cites this paper
• Overview of polymyxin resistance in Enterobacteriaceae

  2022cites this paper
• Genetic Characterization of Colistin-Resistant Salmonella enterica ST34 Co-Harbouring Plasmid-Borne mcr-1, blaCTX-M-15 and blaKPC-2 Recovered from a Paediatric Patient in Shenzhen, China

  2022cites this paper
• Associated resistance of Escherichia coli isolated from humans and animals to polymyxin and beta-lactam antibiotics

  2022cites this paper
• Application of the advanced Marfey’s method for the determination of the absolute configuration of ogipeptins

  2022cites this paper
• Highway to Cell: Selection of the Best Cell-Penetrating Peptide to Internalize the CFTR-Stabilizing iCAL36 Peptide

  2022cites this paper
• Mechanism of action, resistance, synergism, and clinical implications of azithromycin

  2022cites this paper
• Radiation synthesis of pH-sensitive 2-(dimethylamino)ethyl methacrylate/ polyethylene oxide/ZnS nanocomposite hydrogel membrane for wound dressing application

  2022cites this paper
• Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis

  2022cites this paper
• The neuroprotective effect of mesenchymal stem cells in colistin-induced neurotoxicity

  2022cites this paper
• Whole-genome Analyses of APEC carrying mcr-1 in some coastal areas of China from 2019 to 2020.

  2022cites this paper
• Total Synthesis and Structural Elucidation of Ogipeptins.

  2022cites this paper
• Model‐Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients

  2022cites this paper
• Molecular mechanisms and clonal lineages of colistin‐resistant bacteria across the African continent: a scoping review

  2022cites this paper
• A review of recent advances in the treatment of adults with complicated urinary tract infection

  2022cites this paper
• Rapid evolution of colistin resistance in a bioreactor model of infection of Klebsiella pneumoniae

  2022cites this paper
• Core-shell nanosystems designed for effective oral delivery of polypeptide drugs.

  2022cites this paper
• Individualized optimization of colistin loading doses

  2022cites this paper
• Examination of the emerging role of transporters in the assessment of nephrotoxicity

  2022cites this paper
• Detection of Colistin Sulfate on Piglet Gastrointestinal Tract Microbiome Alterations

  2022cites this paper
• Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence

  2022influential citation
• High-risk international clones ST66, ST171 and ST78 of Enterobacter cloacae complex causing blood stream infections in Spain and carrying blaOXA-48 with or without mcr-9.

  2022cites this paper
• Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales: Risk Factors for Mortality, Antimicrobial Therapy and Treatment Outcomes from a Prospective Multicenter Study

  2021cites this paper
• Mobile Colistin Resistance Gene mcr-1 Detected on an IncI2 Plasmid in Salmonella Typhimurium Sequence Type 19 from a Healthy Pig in South Korea

  2021influential citation
• Characteristics, Influencing Factors, Predictive Scoring System, and Outcomes of the Patients with Nephrotoxicity Associated with Administration of Intravenous Colistin

  2021cites this paper
• Rapid antimicrobial susceptibility profiling using impedance spectroscopy.

  2021cites this paper
• Combined With Mefloquine, Resurrect Colistin Active in Colistin-Resistant Pseudomonas aeruginosa in vitro and in vivo

  2021cites this paper
• Quercetin Rejuvenates Sensitization of Colistin-Resistant Escherichia coli and Klebsiella Pneumoniae Clinical Isolates to Colistin

  2021cites this paper
• "Distribution of Colistin Resistance Genes Among Clinical Isolate of Gram-Negative Bacteria"

  2021cites this paper
• Colistin Resistance among Human Clinical Isolates from a Tertiary Care Hospital in Nepal.

  2021cites this paper
• CHROMagar COL-APSE medium as a screening method for fecal carriage of Colistin resistant Enterobacteriaceae among patients in Mansoura university hospitals, Egypt

  2021cites this paper
• Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review

  2021influential citation
• Colistin neurotoxicity mimicking Guillain-Barré syndrome in a patient with cystic fibrosis: case report and review

  2021cites this paper